|
| D5 |
Efficacy and Safety of Oral Phenylephrine: A Systematic Review and Meta-Analysis  (Free Access)
|
| C59 |
Safety of Angiotensin-Converting Enzyme Inhibitors in Patients with Insect Venom Allergies
|
| C34 |
Mometasone Furoate Improves Congestion in Patients with Moderate-to-Severe Seasonal Allergic Rhinitis
|
| C26 |
Antihistamines for Allergic Rhinitis and Chronic Idiopathic Urticaria
|
Return to
Top
|
|
Alternative
Medicine |
| C89 |
Antioxidants, Supplements, and Parkinson's Disease
|
| C14 |
Vitamin E Supplementation in Cardiovacular Disease and Cancer
Prevention: Part 1
|
| C5 |
Treating Pregnancy-Related Nausea and Vomiting with
Ginger
|
B74
|
Adequacy of Aspirin-Related Warnings on Willow Bark
Products
|
B66
|
The
Effect of Creatine Supplementation on Kidney Function
|
B36
|
Effects
of Natural Health Products on Blood Pressure
|
Return to
Top
|
|
Ambulatory Care |
| D5 |
Efficacy and Safety of Oral Phenylephrine: A Systematic Review and Meta-Analysis (Free Access)
|
| C97 |
Optimal Low-Density Lipoprotein Cholesterol Lowering-Morning Versus Evening Statin Administration
|
B83
|
Blood
Clot Risks Associated with COX-2 Inhibitors
|
B78
|
Phosphodiesterase 5 Inhibitors for Erectile
Dysfunction
|
B77
|
Selective Serotonin-Reuptake Inhibitors for the
Treatment of Premature Ejaculation
|
B57
|
Comparison of Point of Care HBA1C Test versus
Standardized Laboratory Testing
|
B56
|
Anticoagulation Monitoring Part 1: Warfarin and
Parenteral Direct Thrombin Inhibitors
|
B43
|
Influence of Warfarin on Symptoms of Fatigue: Findings
of a Randomized Trial
|
B39
|
Discovery, Clinical Development, and Therapeutic Uses
of Bisphosphonates
|
Return to
Top
|
|
Arthritis & Inflammatory
Diseases |
| C64 |
Febuxostat: A Selective Xanthine Oxidase Inhibitor for the Treatment of Hyperuricemia and Gout
|
| C40 |
Rituximab Treatment of Refractory Rheumatoid Arthritis
|
| C6 |
How
Celecoxib Could Be Safer, How Valdecoxib Might Have
Been
|
B84
|
Efalizumab for the Treatment of Moderate to Severe
Plaque Psoriasis
|
B35
|
Factors
Associated with Celecoxib and Rofecoxib Utilization
|
B25
|
Effect
of COX-2 Inhibitors on Blood Pressure
|
B24
|
Macrolides and Tetracyclines for Chronic Inflammatory
Diseases
|
B9
|
Adverse
Drug Events Involving COX-2 Inhibitors
|
B2
|
Nephrotoxic Potential of Selective Cyclooxygenase-2
Inhibitors
|
B1
|
Celebrex-Induced
Methemoglobinemia
|
A28
|
Effect
of Naproxen and Sulindac on Blood Pressure Response to
Atenolol
|
Return to
Top
|
|
Asthma & Other Lung
Diseases |
| D4 |
Concentrated Saline Solution as a Treatment for Cystic Fibrosis
|
| C74 |
Sitaxsentan for Treatment of Pulmonary Hypertension
|
| C69 |
Varenicline for Smoking Cessation
|
| C32 |
Once Daily Mometasone Furoate for Persistent Asthma
|
| C10 |
Aralast: A New Alpha-Protease Inhibitor for Treatment of
Alpha-Antitrypsin Deficiency
|
B87
|
Tiotropium: A Bronchodilator for Chronic Obstructive
Pulmonary Disease
|
B75
|
What’s New with Beta2 -Agonists:
Issues in the Management of Asthma
|
B58
|
Nebulized Morphine for Relief of Dyspnea Due to
Chronic Lung Disease
|
B51
|
Sildenafil for Pulmonary
Hypertension
|
Return to
Top
|
|
Blood
Disorders |
| C65 |
Hemostatic Mouthwashes in Anticoagulated Patients Undergoing Dental Extraction
|
| C29 |
Are Shorter Courses of Filgrastim Prophylaxis Associated with Increased Risk of Hospitalization?
|
| C17 |
Role of Lenalidomide in the Treatment of Multiple Myeloma and Myelodysplastic Syndrome
|
B65
|
Nelarabine: A Nucleoside Analog with Efficacy in
T-Cell and Other Leukemias
|
B64
|
Sulfhemoglobinemia caused by
Phenazopyridine
|
B47
|
Recombinant Factor VIIa in the Treatment of
Non-Hemophiliac Bleeding
|
Return to
Top
|
|
Brain and Central Nervous System
Diseases |
| C89 |
Antioxidants, Supplements, and Parkinson's Disease
|
| C43 |
Role of Risperidone in Children with Autism Spectrum Disorder
|
| C39 |
Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or
Vitamin E
|
| C36 |
Vitamin E Supplementation in Alzheimer's Disease, Parkinson's Disease, Tardive Dyskinesia, and Cataract: Part 2
|
| C31 |
Vitamin C and Vitamin E for Alzheimer's Disease
|
| C30 |
Pregabalin: A New Neuromodulator with Broad Therapeutic Indications
|
| C18 |
Mycophenolate Mofetil Treatment of Myasthenia Gravis
|
| C9 |
Natalizumab for the Treatment of Multiple Sclerosis and Crohn's
Disease
|
| C8 |
Eszopiclone for Insomnia
|
| C7 |
Open
Trial of Pindolol in the Treatment of Fibromyalgia
|
B70
|
Use
of Methylphenidate in Traumatic Brain Injury
|
B30
|
Impact of Topiramate on Serum Bicarbonate
Concentrations in Adults
|
B19
|
Effect
of Cotherapy Reduction on Tolerability of Epilepsy Add-on
Therapy
|
Return to
Top
|
|
Cancer |
| C29 |
Are Shorter Courses of Filgrastim Prophylaxis Associated with Increased Risk of Hospitalization?
|
| C28 |
Efaproxiral: A Radiation Enhancer Used in Brain Metastases from Breast Cancer
|
| C23 |
Current Status of Cetuximab for the Treatment of Patients with Solid Tumors
|
| C20 |
Lapatinib: A Novel Dual Tyrosine Kinase Inhibitor with Activity in Solid Tumors
|
| C17 |
Role of Lenalidomide in the Treatment of Multiple Myeloma and Myelodysplastic Syndrome
|
| C11 |
Thalidomide-Associated Thrombocytopenia
|
| C14 |
Vitamin E Supplementation in Cardiovacular Disease and Cancer
Prevention: Part 1
|
B80
|
Zoledronic Acid and Renal Toxicity : Data from French
Adverse Effect Reporting Database
|
B65
|
Nelarabine: A Nucleoside Analog with Efficacy in
T-Cell and Other Leukemias
|
B48
|
Dyspnea
During Thalidomide Treatment for Advanced Ovarian
Cancer
|
B40
|
Pemetrexed Therapy for Malignant Pleural
Mesothelioma
|
B23
|
Aprepitant (Emend) for Chemotherapy-Induced
Vomiting
|
B22
|
Pentoxifylline and Vitamin E to Reduce
Radiation-Induced Fibrosis
|
B17
|
Treatment of Opioid-Induced
Sedation
|
Return to
Top
|
|
Care of the
Elderly |
| C89 |
Antioxidants, Supplements, and Parkinson's Disease
|
| C71 |
Prostate Cancer Treatment: Detrimental to Bones
|
| C3 |
Parathyroid Hormone (1-84) and Treatment of
Osteoporosis
|
B86
|
Once-Weekly Alendronate in Asian Postmenopausal Women
with Osteoporosis
|
B39
|
Discovery, Clinical Development, and Therapeutic Uses
of Bisphosphonates
|
B29
|
Side
Effects Resulting from Inappropriate Medication Use in Nursing
Homes
|
A17
|
Coadministration of Gatifloxacin and Multivitamin
Preparation Containing Minerals: Potential Treatment Failure in an Elderly
Patient
|
Return to
Top
|
|
Children's
Health |
| D4 |
Concentrated Saline Solution as a Treatment for Cystic Fibrosis
|
| C82 |
Iron Supplements in Infants: Is there a Risk of Poisoning?
|
| C48 |
Prevalence and Treatment of Metabolic Syndrome in Adolescents with Type 2 Diabetes
|
| C43 |
Role of Risperidone in Children with Autism Spectrum Disorder
|
| C13 |
Otitis
Media: Review of 2004 Treatment Guidelines
|
B76
|
Clinical Experience with Spironolactone in
Children
|
B62
|
Atomoxetine Ingestions in Children: A Report from
Poison Centers
|
B60
|
Oral Sucrose to Reduce Pain During Eye Examinations of
Premature Infants
|
B49
|
Efficacy of Topical Anesthetics to Reduce Pain in
Premature Infants During Eye Examinations for Retinopathy of
Prematurity
|
B38
|
Prokinetic Drug Therapy in Children: A Review of
Current Options
|
B26
|
Isotretinoin (Accutane) and Psychiatric Illness in
Adolescents an Young Adults
|
A27
|
The
Potential Role of Statins in Pediatric Nephrotic
Syndrome
|
A24
|
Over-the-Counter Cough and Cold Medicines: Should
Parents Be Using Them for Their Children?
|
A21
|
Single
High-Dose Rectal Acetaminophen (Tylenol, Feverall) in
Children
|
A11
|
Television and Adolescent Use of Over-the-Counter
Analgesic Agents
|
Return to
Top
|
|
Diabetes |
| D3 |
Can Metformin be Used Safely in Patients that have Diabetes and Heart Failure?
|
| C78 |
Sitagliptin: New Drug for Type 2 Diabetes
|
| C57 |
Effect of Glucosamine on Glucose Control
|
| C55 |
Ruboxistaurin, a Protease Kinase C Beta Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications
|
| C52 |
Orlistat Nears Over-the-Counter Approval for Obesity
|
| C48 |
Prevalence and Treatment of Metabolic Syndrome in Adolescents with Type 2 Diabetes |
| C42 |
Liver Toxicity Associated with Acarbose Therapy
|
| C2 |
Lipid
Management with Statins in Type 2 Diabetes Mellitus
|
B57
|
Comparison of Point of Care HBA1C Test versus
Standardized Laboratory Testing
|
B52
|
Inhaled
Insulin (Exubera)
|
B21
|
Rimonabant–A New Medication for Weight Loss and
Smoking Cessation
|
B18
|
Effect
of Lipid-Lowering Drug Therapy on Small-Dense Low-Density
Lipoprotein
|
B7
|
Intensive Insulin Therapy for Critically
Ill
|
A22
|
Insulin
Strategies for Type 2 Diabetes Mellitus
|
A18
|
The
Metabolic Syndrome: Pathophysiology, Clinical Relevance, and Use of
Niacin
|
Return to
Top
|
|
Digestive System
Diseases |
| C49 |
GI Risk Factors and Use of GI Protective Agents Among Patients Receiving Nonsteroidal Antiinflammatory Drugs
|
| C9 |
Natalizumab for the Treatment of Multiple Sclerosis and Crohn's
Disease
|
B42
|
Reducing the Risk of Spontaneous Bacterial Peritonitis
in Patients with Cirrhosis
|
B38
|
Prokinetic Drug Therapy in Children: A Review of
Current Options
|
B15
|
Rifaximin: A New Treatment for Travelers'
Diarrhea
|
Return to
Top
|
|
Drug and Alcohol Abuse |
B21
|
Rimonabant–A New Medication for Weight Loss and
Smoking Cessation
|
A29
|
Smoking
Cessation: A Pilot Study of the Effects of Health-Related Quality of Life and
Perceived Work Performance One Week into the Attempt
|
A16
|
Antimuscarinic Intoxication Resulting from the
Ingestion of Moonflower Seeds
|
Return to
Top
|
|
Drug
Interactions |
| C70 |
Interaction Between Corticosteroids and Warfarin
|
B41
|
Decreased Warfarin Effect After Initiation of
High-Protein, Low-Carbohydrate Diets
|
B31
|
Potential Drug-Disease Interactions in Frail,
Hospitalized Elderly Veterans
|
B5
|
Avelox-Coumadin Interaction: A Series of Five Case
Reports
|
B4
|
Concomitant Coumarin-NSAID Therapy and Risk for
Bleeding
|
A28
|
Effect
of Naproxen and Sulindac on Blood Pressure Response to
Atenolol
|
Return to
Top
|
|
Eye Diseases |
| C81 |
Advances in Treatment of Uveitis
|
B60
|
Oral
Sucrose to Reduce Pain During Eye Examinations of Premature
Infants
|
B49
|
Efficacy of Topical Anesthetics to Reduce Pain in
Premature Infants During Eye Examinations for Retinopathy of
Prematurity
|
Return to
Top
|
|
General
Medicine |
| D5 |
Efficacy and Safety of Oral Phenylephrine: A Systematic Review and Meta-Analysis
|
| C69 |
Varenicline for Smoking Cessation
|
| C64 |
Febuxostat: A Selective Xanthine Oxidase Inhibitor for the Treatment of Hyperuricemia and Gout
|
| C53 |
Physician's Knowledge of Out-of-Pocket Costs for Prescription Drugs
|
| C51 |
Renin-Angiotensin System Mediators and Raynaud's Phenomenon
|
| C28 |
Telbivudine: A Novel Nucleoside Analog for Chronic Hepatitis B
|
B79
|
FDA
Policy on Unapproved Drug Products: Past, Present, and
Future
|
B42
|
Reducing the Risk of Spontaneous Bacterial Peritonitis
in Patients with Cirrhosis
|
B21
|
Rimonabant–A New Medication for Weight Loss and
Smoking Cessation
|
B15
|
Rifaximin: A New Treatment for Traveler's
Diarrhea
|
A29
|
Smoking
Cessation: A Pilot Study of the Effects on Health-Related Quality of Life and
Perceived Work Performance One Week into the Attempt
|
A25
|
Patient
and Physician Attitudes to Using Medications with Religiously Forbidden
Ingredients
|
A23
|
Calcimimetics and the Treatment of Primary and
Secondary Hyperparathyroidism
|
Return to
Top
|
|
Heart Disease |
| D3 |
Can Metformin be Used Safely in Patients that have Diabetes and Heart Failure?
|
| C97 |
Optimal Low-Density Lipoprotein Cholesterol Lowering-Morning Versus Evening Statin Administration
|
| C87 |
Considerations for Supplementing with Coenzyme Q10 During Statin Therapy
|
| C86 |
Increased Sensitivity to Warfarin After Heart Valve Replacement
|
| C70 |
Interaction Between Corticosteroids and Warfarin
|
| C66 |
Efficacy and Safety of Rosuvastatin Every Other Day Compared with Once Daily in Patients with Hypercholesterolemia
|
| C65 |
Hemostatic Mouthwashes in Anticoagulated Patients Undergoing Dental Extraction
|
| C45 |
Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure
|
| C24 |
Blood Pressure and Heart Rate Effects Following a Single Dose of Bitter Orange
|
| C21 |
Ranolazine: A New Approach to Management of Patients with Angina
|
| C16 |
AGI-1067: A Novel Vascular Protectant for Prevention of Restenosis
|
| C14 |
Vitamin E Supplementation in Cardiovacular Disease and Cancer
Prevention: Part 1
|
| C2 |
Lipid
Management with Statins in Type 2 Diabetes Mellitus
|
B85
|
The
Role of Coenzyme Q10 in Heart Failure
|
B82
|
Effect
of Prophylactic Amiodarone on Clinical and Economic Outcomes After
Cardiothoracic Surgery: A Meta-Analysis
|
B76
|
Clinical Experience with Spironolactone in
Children
|
B72
|
Morning
Coffee Does Not Affect LDL Cholesterol Level
|
B68
|
Are
Brand-Name and Generic Warfarin Interchangeable?
|
B67
|
Low-Dose Warfarin to Prevent Unwanted Blood Clots
After Orthopedic Surgery
|
B63
|
Impact
of Nonsteroidal Antiinflammatory Drugs on the Cardioprotective Effects of
Aspirin
|
B59
|
The
Influence of Ethnicity on Warfarin Dosage Requirement
|
B56
|
Anticoagulation Monitoring Part 1: Warfarin and
Parenteral Direct Thrombin Inhibitors
|
B43
|
Influence of Warfarin on Symptoms of Fatigue: Findings
of a Randomized Trial
|
B41
|
Decreased Warfarin Effect After Initiation of
High-Protein, Low-Carbohydrate Diets
|
B32
|
Angiotensin Receptor Blockers versus ACE Inhibitors in
the Prevention of Death and Heart Attack
|
B20
|
Valsartan in Chronic Heart
Failure
|
B18
|
Effect
of Lipid-Lowering Drug Therapy on Small-Dense Low-Density
Lipoprotein
|
B16
|
Guidelines for Acute Decompensated Heart Failure
Treatment
|
B12
|
Analysis of Aspirin-Associated Risks in Healthy
Individuals
|
B10
|
Intensive Lipid-Lowering Therapy in Patients with
Coronary Heart Disease
|
B5
|
Avelox-Coumadin Interaction: A Series of Five Case
Reports
|
B4
|
Concomitant Coumarin-NSAID Therapy and Risk for
Bleeding
|
A18
|
The
Metabolic Syndrome: Pathophysiology, Clinical Relevance, and Use of
Niacin
|
Return to
Top
|
|
HIV/AIDS |
| C58 |
Fosamprenavir: Drug Development for Adherence
|
B81
|
Once-Daily Abacavir in Place of Twice-Daily
Administraton
|
B37
|
Inadequate Nevirapine Levels and Virologic Rebounds in
HIV-Infected Patients Who Switched from Protease
Inhibitors
|
B27
|
Selective Serotonin-Reuptake Inhibitors for Depression
in Adults with HIV
|
Return to
Top
|
|
Hormonal
Diseases |
A23
|
Calcimimetics and the Treatment of Primary and
Secondary Hyperparathyroidism
|
Return to
Top
|
|
Hypertension and Blood Vessel Disorders
|
| C83 |
Aliskiren for High Blood Pressure
|
| C80 |
Lercanidipine for High Blood Pressure
|
| C51 |
Renin-Angiotensin System Mediators and Raynaud's Phenomenon
|
B36
|
Effects
of Natural Health Products on Blood Pressure
|
B28
|
Blood
Pressure Treatment Adherence with Different Formulations of
Nifedipine
|
B25
|
Effect
of COX-2 Inhibitors on Blood Pressure
|
A3
|
Effect
of Naproxen and Sulindac on Blood Pressure Response to
Atenolol
|
Return to
Top
|
|
Infectious
Diseases |
| C76 |
Past, Present, and Future Therapies for Clostridium difficile-Associated Disease
|
| C72 |
Emerging Therapies for Clostridium difficile Diarrhea
|
| C62 |
Inhaled Amphotericin B for Prophylaxis Against Invasive Aspergillus Infections
|
| C58 |
Fosamprenavir: Drug Development for Adherence
|
| C56 |
The Potential Role of Roflumilast: The New Phosphodiesterase-4 Inhibitor
|
| C13 |
Otitis
Media: Review of 2004 Treatment Guidelines
|
B81
|
Once-Daily Abacavir in Place of Twice-Daily
Administraton
|
B69
|
Thrombocytosis During Antifungal Therapy of
Candidemia
|
B55
|
Generalized Seizure and Toxic Epidermal Necrolysis
Following Levofloxacin Exposure
|
B37
|
Inadequate Nevirapine Levels and Virologic Rebounds in
HIV-Infected Patients Who Switched from Protease
Inhibitors
|
B34
|
Norfloxacin-Induced Toxic Epidermal
Necrolysis
|
B15
|
Rifaximin: A New Treatment for Travelers'
Diarrhea
|
B3
|
Role of
Corticosteroids in Septic Shock
|
A21
|
Single
High-Dose Rectal Acetaminophen (Tylenol, Feverall) in
Children
|
A17
|
Coadministration of Gatifloxacin and Multivitamin
Preparation Containing Minerals: Potential Treatment Failure in an Elderly
Patient
|
A4
|
Adjunctive Granulocyte Colony-Stimulating Factor
Therapy (G-CSF) for Diabetic Foot Infections
|
A3
|
Flumist
(Trivalent Intranasal Influenza Vaccine, Live)
|
Return to
Top
|
|
Intensive Care |
B7
|
Intensive Insulin Therapy for Critically
Ill
|
B3
|
Role of
Corticosteroids in Septic Shock
|
Return to
Top
|
|
Kidney Disease |
| C85 |
Lanthanum Carbonate
|
B66
|
The
Effect of Creatine Supplementation on Kidney Function
|
B54
|
Effect
of Indapamide on Urinary Calcium Excretion in Patients With and Without Urinary
Stone Disease
|
B2
|
Nephrotoxic Potential of Selective Cyclooxygenase-2
Inhibitors
|
A12
|
Assessment for Chronic Kidney Disease in High-Risk
Patients at Community Health Clinics
|
A27
|
The
Potential Role of Statins in Pediatric Nephrotic
Syndrome
|
Return to
Top
|
|
Medication
Information |
| C53 |
Physician's Knowledge of Out-of-Pocket Costs for Prescription Drugs
|
| C6 |
How
Celecoxib Could Be Safer, How Valdecoxib Might Have
Been
|
B79
|
FDA
Policy on Unapproved Drug Products: Past, Present, and
Future
|
B33
|
Ask the
Pharmacist: An Analysis of Online Drug Information
Services
|
B11
|
The
Impact of New Drugs on Drug Spending in Primary Health
Care
|
B8
|
Why
Aren't Lower, Effective, OTC Doses Available Earlier by
Prescription?
|
A25
|
Patient
and Physician Attitudes to Using Medications with Religiously Forbidden
Ingredients
|
A2
|
Not All
Sulfa Drugs Are Created Equal
|
Return to
Top
|
|
Medication Safety |
| D5 |
Efficacy and Safety of Oral Phenylephrine: A Systematic Review and Meta-Analysis (Free Access)
|
| C49 |
GI Risk Factors and Use of GI Protective Agents Among Patients Receiving Nonsteroidal Antiinflammatory Drugs
|
| C11 |
Thalidomide-Associated Thrombocytopenia
|
| C6 |
How
Celecoxib Could Be Safer, How Valdecoxib Might Have
Been
|
B80
|
Zoledronic Acid and Renal Toxicity: Data from French
Adverse Effect Reporting Database
|
B79
|
FDA
Policy on Unapproved Drug Products: Past, Present, and
Future
|
B31
|
Potential Drug-Disease Interactions in Frail,
Hospitalized Elderly Veterans
|
B29
|
Side
Effects Resulting from Inappropriate Medication Use in Nursing
Homes
|
B25
|
Effect
of COX-2 Inhibitors on Blood Pressure
|
B9
|
Adverse
Drug Events Involving COX-2 Inhibitors
|
B8
|
Why
Aren't Lower, Effective, OTC Drugs Available Earlier by
Prescription?
|
B5
|
Avelox-Coumadin Interaction: A Series of Five Case
Reports
|
B4
|
Concomitant Coumarin-NSAID Therapy and Risk for
Bleeding
|
B2
|
Nephrotoxic Potential of Selective Cyclooxygenase-2
Inhibitors
|
B1
|
Celebrex-Induced
Methemoglobinemia
|
A20
|
Antidepressants: An Avoidable and Solvable
Controversy
|
A19
|
Antidepressants, Suicide and the FDA: A Loose
Association
|
A2
|
Not All
Sulfa Drugs Are Created Equal
|
Return to
Top
|
|
Men's Health |
| C71 |
Prostate Cancer Treatment: Detrimental to Bones
|
| C14 |
Effect of Bupropion on Sexual Dysfunction
|
B78
|
Phosphodiesterase 5 Inhibitors for Erectile
Dysfunction
|
B77
|
Selective Serotonin-Reuptake Inhibitors for the
Treatment of Premature Ejaculation
|
Return to
Top
|
|
Obstetrics/Gynecology |
| C19 |
Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient
|
| C5 |
Treating Pregnancy-Related Nausea and Vomiting with
Ginger
|
B71
|
Theoretical Mechanisms of Mifepristone
(RU-486)-Induced Septic Shock After Chemical Abortion
|
B50
|
Antidepressant Use During Pregnancy and the Occurrence
of Spontaneous Miscarriages
|
B14
|
Postfertilization Effect of Hormonal Emergency
Contraception
|
A15
|
High-Versus Low-Dose Oxytocin for Augmentation or
Induction of Labor
|
A9
|
Challenges to the FDA Approval of
Mifepristone
|
Return to
Top
|
|
Pain Management |
| C84 |
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
|
| C49 |
GI Risk Factors and Use of GI Protective Agents Among Patients Receiving Nonsteroidal Antiinflammatory Drugs
|
| C35 |
Botulinum Toxin Type A for the Prevention and Treatment of Migraine Headaches
|
| C6 |
How
Celecoxib Could Be Safer, How Valdecoxib Might Have
Been
|
B83
|
Blood
Clot Risks Associated with COX-2 Inhibitors
|
B63
|
Impact
of Nonsteroidal Antiinflammatory Drugs on the Cardioprotective Effects of
Aspirin
|
B61
|
Long-Term Treatment with Glucosamine and the
Progresssion of Knee Osteoarthritis
|
B58
|
Nebulized Morphine for Relief of Dyspnea Due to
Chronic Lung Disease
|
B53
|
Etoricoxib: A Highly Selective COX-2
Inhibitor
|
B35
|
Factors
Associated with Celecoxib and Rofecoxib Utilization
|
B25
|
Effect
of COX-2 Inhibitors on Blood Pressure
|
B17
|
Treatment of Opioid-Induced
Sedation
|
B9
|
Adverse
Drug Events Involving COX-2 Inhibitors
|
B4
|
Concomitant Coumarin-NSAID Therapy and Risk for
Bleeding
|
B2
|
Nephrotoxic Potential of Selective Cyclooxygenase-2
Inhibitors
|
B1
|
Celebrex-Induced
Methemoglobinemia
|
A11
|
Television and Adolescent Use of Over-the-Counter
Analgesic Agents
|
A28
|
Effect
of Naproxen and Sulindac on Blood Pressure Response to
Atenolol
|
Return to
Top
|
|
Poison Control |
| C82 |
Iron Supplements in Infants: Is there a Risk of Poisoning?
|
B62
|
Atomoxetine Ingestions in Children: A Report from
Poison Centers
|
A13
|
Poisoning in Older Adults: A 5-Year Experience of US
Poison Control Centers
|
Return to
Top
|
|
Psychiatry |
| C75 |
Aripirazole May Help Depression in Bipolar Disorder?
|
| C68 |
Allopurinol May Help Treatment-Resistant Schizophrenia
|
| C63 |
Olanzapine in Treatment of Anorexia Nervosa
|
| C61 |
Risk of Clozapine-Associated Agranulocytosis and Mandatory White Blood Cell Monitoring
|
| C47 |
Cost-Effectiveness Analysis of Escitalopram Compared with Paroxetine in Treatment of Generalized Anxiety Disorder in the United Kingdom
|
| C15 |
Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles
|
| C12 |
Duloxetine and Venlafaxine-XR in the Treatment of Major
Depressive Disorder: A Meta-Analysis of Randomized Clinical
Trials
|
| C8 |
Eszopiclone for Insomnia
|
| C4 |
Antipsychotic Dose-Sparing Effect with Addition of
Memantine
|
B62
|
Atomoxetine Ingestions in Children: A Report from
Poison Centers
|
B50
|
Antidepressant Use During Pregnancy and the Occurrence
of Spontaneous Miscarriages
|
B27
|
Selective Serotonin-Reuptake Inhibitors for Depression
in Adults with HIV
|
B26
|
Isotretinoin (Accutane) and Psychiatric Illness in
Adolescents and Young Adults
|
B6
|
Current
Options in the Management of Zyprexa-Associated Weight
Gain
|
A20
|
Antidepressants: An Avoidable and Solvable
Controversy
|
A19
|
Antidepressants, Suicide and the FDA: A Loose
Association
|
A14
|
Risperdal Consta (Long-Acting Injectable
Risperidone)
|
A1
|
Cymbalta: A Dual Reuptake
Inhibitor
|
Return to
Top
|
|
Side Effects of
Medications |
| C61 |
Risk of Clozapine-Associated Agranulocytosis and Mandatory White Blood Cell Monitoring
|
| C60 |
Hepatitis Associated with Low-Dose Venlafaxine for Postmenopausal Vasomotor Symptoms
|
| C42 |
Liver Toxicity Associated with Acarbose Therapy
|
| C41 |
Medications Associated with Weight Gain
|
| C11 |
Thalidomide-Associated Thrombocytopenia
|
| C6 |
How
Celecoxib Could Be Safer, How Valdecoxib Might Have
Been
|
B55
|
Generalized Seizure and Toxic Epidermal Necrolysis
Following Levofloxacin Exposure
|
B48
|
Dyspnea
During Thalidomide Treatment for Advanced Ovarian
Cancer
|
B34
|
Norfloxacin-Induced Toxic Epidermal
Necrolysis
|
B30
|
Impact
of Topiramate on Serum Bicarbonate Concentrations in
Adults
|
B29
|
Side
Effects Resulting from Inappropriate Medication Use in Nursing
Homes
|
B26
|
Isotretinoin (Accutane) and Psychiatric Illness in
Adolescents and Young Adults
|
B25
|
Effect
of COX-2 Inhibitors on Blood Pressure
|
B12
|
Analysis of Aspirin-Associated Risks in Healthy
Individuals
|
B9
|
Adverse
Drug Events Involving COX-2 Inhibitors
|
B8
|
Why
Aren't Lower, Effective, OTC Doses Available Earlier by
Prescription?
|
B2
|
Nephrotoxic Potential of Selective Cyclooxygenase-2
Inhibitors
|
B1
|
Celebrex-Induced
Methemoglobinemia
|
A10
|
Prolonged Thrombocytopenia Associated with
Isotretinoin
|
A2
|
Not All
Sulfa Drugs Are Created Equal
|
Return to
Top
|
|
Skin Diseases |
B84
|
Efalizumab for the Treatment of Moderate to Severe
Plaque Psoriasis
|
B34
|
Norfloxacin-Induced Toxic Epidermal
Necrolysis
|
B26
|
Isotretinoin (Accutane) and Psychiatric Illness in
Adolescents and Young Adults
|
A10
|
Prolonged Thrombocytopenia Associated with
Isopretinoin
|
Return to
Top
|
|
Surgery |
| C65 |
Hemostatic Mouthwashes in Anticoagulated Patients Undergoing Dental Extraction
|
B88
|
Alvimopan for the Management of Postoperative
Ileus
|
B82
|
Effect
of Prophylactic Amiodarone on Clinical and Economic Outcomes After
Cardiothoracic Surgery: A Meta-Analysis
|
B67
|
Low-Dose Warfarin to Prevent Unwanted Blood Clots
After Orthopedic Surgery
|
B47
|
Recombinant Factor VIIa in the Treatment of
Non-Hemophiliac Bleeding
|
Return to
Top
|
|
| C27 |
Modified-Release Tacrolimus for Organ Transplantation
|
Return to
Top
|
|
Urinary Tract
Diseases |
B64
|
Sulfhemoglobinemia caused by
Phenazopyridine
|
B54
|
Effect
of Indapamide on Urinary Calcium Excretion in Patients With and Without Urinary
Stone Disease
|
B13
|
Undertreatment of Urinary Incontinence in General
Practice
|
Return to
Top
|
|
Weight
Management |
| C54 |
Topiramate for Binge-Eating Disorder Associated with Obesity
|
| C52 |
Orlistat Nears Over-the-Counter Approval for Obesity
|
| C48 |
Prevalence and Treatment of Metabolic Syndrome in Adolescents with Type 2 Diabetes
|
B73
|
Medications That Cause Weight Gain May Reduce Success
of a Weight Management Program
|
Return to
Top
|
|
Women's Health |
| C88 |
Use of Sildenafil for Female Sexual Dysfunction
|
| C60 |
Hepatitis Associated with Low-Dose Venlafaxine for Postmenopausal Vasomotor Symptoms
|
| C38 |
Effect of Bupropion on Sexual Dysfunction
|
| C28 |
Efaproxiral: A Radiation Enhancer Used in Brain Metastases from Breast Cancer
|
| C22 |
Effect of Vitamin A on Fracture Risk
|
| C19 |
Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient
|
| C5 |
Treating Pregnancy-Related Nausea and Vomiting with
Ginger
|
| C3 |
Parathyroid Hormone (1-84) and Treatment of
Osteoporosis
|
| C1 |
Spironolactone for Dirsutism in Polycystic Ovary
Syndrome
|
B86
|
Once-Weekly Alendronate in Asian Postmenopausal Women
with Osteoporosis
|
B71
|
Theoretical Mechanisms of Mifepristone
(RU-486)-Induced Septic Shock After Chemical Abortion
|
B39
|
Discovery, Clinical Development, and Therapeutic Uses
of Bisphosphonates
|
B14
|
Postfertilization Effect of Hormonal Emergency
Contraception
|
B13
|
Undertreatment of Urinary Incontinence in General
Practice
|
Return to
Top
|
